Raymond James Financial
ENZ

Raymond James Financial’s Enzo Biochem, Inc. ENZ Stock Holding History

Raymond James Financial’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,016
Closed -$6.3K – 7071
2025
Q1 		$6.3K Hold
17,016
– – ﹤0.01% 4794
2024
Q4 		$12.2K Buy
+17,016
New +$17.6K ﹤0.01% 4764

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Raymond James Financial's ENZ Position: Q2 2025 in Review

Raymond James Financial sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 17,016 shares — an estimated $6.3K sold.

Raymond James Financial first reported a position in ENZ in Q4 2024 and held it in 2 quarters. The position peaked at $12.2K in Q4 2024. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Raymond James Financial reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Raymond James Financial sold 17,016 Enzo Biochem, Inc. shares in Q2 2025, an estimated $6.3K.
  • Raymond James Financial first reported a position in Enzo Biochem, Inc. in Q4 2024 and held it in 2 quarters.
  • Raymond James Financial's Enzo Biochem, Inc. position peaked at $12.2K in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.